Park Medi World Limited , formerly known as Park Medi World Private Limited and operating as Park Group of Hospitals, has informed stock exchanges that its Board of Directors approved the acquisition of V3 Healthcare Private Limited, which operates The Medicity Hospital in Rudrapur, Uttarakhand. The board meeting was held on May 25, 2026, commencing at 7:30 a.m. and concluding at 9:10 a.m. The disclosure was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The total consideration for the acquisition is approximately ₹177 crore, to be paid entirely in cash through the purchase of existing shareholding of V3 Healthcare Private Limited in two tranches. Park Medi World will acquire 80% of the shareholding by August 31, 2026, with the remaining 20% to be acquired by April 30, 2030. No regulatory or governmental approvals are required to complete the transaction, and the deal does not constitute a related party transaction.
The Medicity Hospital is a 330-bed multi-super speciality facility located at Teen Pani, Udham Singh Nagar, Kichha Road, Rudrapur, Uttarakhand — 263153. Incorporated on July 15, 2014, the hospital is NABH-accredited and is described as the largest hospital in the Kumaon region. It offers over 20 specialities including Cardiac Sciences, Neurosurgery, Oncology, Orthopedics, Nephrology, Gastroenterology, IVF and Infertility, and Interventional Radiology, among others. The target entity reported turnover of ₹42.46 crore in FY2023-24, ₹49.04 crore in FY2024-25, and ₹55.74 crore (unaudited) in FY2025-26, reflecting steady revenue growth over three years.
Park Medi World has stated that the acquisition aligns with its stated growth strategy of expanding into high-potential, underserved markets by deploying assets to achieve operational synergies and economies of scale. The Kumaon belt of Uttarakhand represents a geography with limited large-format tertiary care infrastructure, making the target asset strategically relevant for the acquirer’s regional expansion.
The acquisition values the hospital at approximately 3.2 times its FY26 revenue, based on the disclosed consideration of ₹177 crore against turnover of ₹55.74 crore — a metric investors and analysts are likely to assess in the context of comparable healthcare M&A transactions in India.
Based solely on the regulatory filing submitted by Park Medi World Limited to NSE and BSE on May 25, 2026.